To further explored the underlying mechanisms of USP13 in NAFLD, RNA sequencing of livers in HFD AAV-GFP and HFD AAV-USP13 mice was conducted, and subsequent KEGG pathway enrichment analysis and GSEA were performed. Here, USP13 is linked to metabolic dysfunction-associated steatotic liver disease.